BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 27239108)

  • 1. Current and emerging therapies in unresectable and recurrent gastric cancer.
    Jou E; Rajdev L
    World J Gastroenterol; 2016 May; 22(20):4812-23. PubMed ID: 27239108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of advanced gastric cancer: the role of new molecular drugs.
    De Vita F; Di Martino N; Fabozzi A; Laterza MM; Ventriglia J; Savastano B; Petrillo A; Gambardella V; Sforza V; Marano L; Auricchio A; Galizia G; Ciardiello F; Orditura M
    World J Gastroenterol; 2014 Oct; 20(40):14537-58. PubMed ID: 25356019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing strategies for target therapy in gastric cancer.
    Lee SY; Oh SC
    World J Gastroenterol; 2016 Jan; 22(3):1179-89. PubMed ID: 26811656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
    Joo MK; Park JJ; Chun HJ
    World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized medicine in gastric cancer: Where are we and where are we going?
    Jácome AA; Coutinho AK; Lima EM; Andrade AC; Dos Santos JS
    World J Gastroenterol; 2016 Jan; 22(3):1160-71. PubMed ID: 26811654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Companion diagnostics for the targeted therapy of gastric cancer.
    Yoo C; Park YS
    World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on metastatic gastric and esophageal cancers.
    Shah MA
    J Clin Oncol; 2015 Jun; 33(16):1760-9. PubMed ID: 25918288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances of Molecular Targeted Therapy in Gastric Cancer.
    Cetin B; Gumusay O; Cengiz M; Ozet A
    J Gastrointest Cancer; 2016 Jun; 47(2):125-34. PubMed ID: 26875080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapies in gastric cancer and future perspectives.
    Yazici O; Sendur MA; Ozdemir N; Aksoy S
    World J Gastroenterol; 2016 Jan; 22(2):471-89. PubMed ID: 26811601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New targeted therapies in pancreatic cancer.
    Seicean A; Petrusel L; Seicean R
    World J Gastroenterol; 2015 May; 21(20):6127-45. PubMed ID: 26034349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances and future trends in the targeted therapy of metastatic gastric cancer.
    Al-Batran SE; Werner D
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):555-69. PubMed ID: 24665840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of Gastric Cancer.
    Strand MS; Lockhart AC; Fields RC
    Surg Clin North Am; 2017 Apr; 97(2):345-370. PubMed ID: 28325191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targeting to treat gastric cancer.
    Aoyagi K; Kouhuji K; Kizaki J; Isobe T; Hashimoto K; Shirouzu K
    World J Gastroenterol; 2014 Oct; 20(38):13741-55. PubMed ID: 25320512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and Future Therapies for Advanced Gastric Cancer.
    Davidson M; Okines AF; Starling N
    Clin Colorectal Cancer; 2015 Dec; 14(4):239-50. PubMed ID: 26524924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapy in gastric cancer.
    Thiel A; Ristimäki A
    APMIS; 2015 May; 123(5):365-72. PubMed ID: 25706252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
    Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
    World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapy in advanced gastric carcinoma: the future is beginning.
    Schinzari G; Cassano A; Orlandi A; Basso M; Barone C
    Curr Med Chem; 2014; 21(8):1026-38. PubMed ID: 24304282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of therapeutic approaches to gastric cancer.
    Wu K; Nie Y; Guo C; Chen Y; Ding J; Fan D
    J Gastroenterol Hepatol; 2009 Jan; 24(1):37-41. PubMed ID: 19196394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.